Atomoxetine and Fluoxetine Activate AMPK-ACC-CPT1 Pathway in Human SH-SY5Y and U-87 MG Cells
Open Access
- 25 March 2023
- journal article
- research article
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 20 (3) , 212-219
Abstract
Objective Atomoxetine and fluoxetine are psychopharmacologic agents associated with loss of appetite and weight. Adenosine monophosphate-activated protein kinase (AMPK) is the cellular energy sensor that regulate metabolism and energy, being activated by fasting and inhibited by feeding in the hypothalamus.Methods Human brain cell lines (SH-SY5Y and U-87 MG cells) were used to study the outcome of atomoxetine and fluoxetine treatment in the activity of AMPK-acetyl-CoA carboxylase (ACC)- carnitine palmitoyl transferase 1 (CPT1) pathway and upstream regulation by calcium/calmodulin-dependent kinase kinase β (CaMKKβ) using immunoblotting and CPT1 enzymatic activity measures.Results Phosphorylation of AMPK and ACC increased significantly after atomoxetine and fluoxetine treatment in the first 30–60 minutes of treatment in the two cell lines. Activation of AMPK and inhibition of ACC was associated with an increase by 5-fold of mitochondrial CPT1 activity. Although the neuronal isoform CPT1C could be detected by immunoblotting, activity was not changed by the drug treatments. In addition, the increase in phospho-AMPK and phospho-ACC expression induced by atomoxetine was abolished by treatment with STO-609, a CaMKKβ inhibitor, indicating that AMPK-ACC-CPT1 pathway is activated through CaMKKβ phosphorylation.Conclusion These findings indicate that at the cellular level atomoxetine and fluoxetine treatments may activate AMPK-ACC-CPT1 pathways through CaMKKβ in human SH-SY5Y and U-87 MG cells.Keywords
Funding Information
- Korea Health Industry Development Institute
- Ministry of Health and Welfare (A120013, HI18C1077)
- National Research Foundation of Korea (2018R1A2B003640)
- Dongguk University
This publication has 49 references indexed in Scilit:
- Role of AMP‐Activated Protein Kinase in the Control of AppetiteJournal of Neuroendocrinology, 2008
- CPT1c Is Localized in Endoplasmic Reticulum of Neurons and Has Carnitine Palmitoyltransferase ActivityJournal of Biological Chemistry, 2008
- Serotonergic DrugsDrugs, 2007
- Molecular disruption of hypothalamic nutrient sensing induces obesityNature Neuroscience, 2006
- The Ca2+/Calmodulin-dependent Protein Kinase Kinases Are AMP-activated Protein Kinase KinasesJournal of Biological Chemistry, 2005
- Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cellsCell Metabolism, 2005
- Body weight is regulated by the brain: a link between feeding and emotionMolecular Psychiatry, 2005
- The Cost of Cortical ComputationCurrent Biology, 2003
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995